Iantech will use the funding to further R&D and commercial efforts for its miLOOP technology, which has the potential to significantly improve global efforts to address cataract-induced visual impairment
Staff at the Bill & Melinda Gates Foundation and J.P. Morgan said they hope the Global Health Investment Fund will demonstrate that it is possible to generate social impact, reduce costs to health care systems and deliver financial returns to investors at the same time.
“Social-impact investing might often be about the intangible benefits provided to society. When it comes to your portfolio, however, you want to be sure the financial returns delivered aren’t intangible, but very real.”
GHIF will give individual and institutional investors their first ever opportunity to finance late-stage global health technologies that have the potential to save millions of lives in low-income countries